Tradestie Institutional Equity Comparison Engine

CVM vs DCTH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DCTH Overall Edge

DCTH Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Delcath Systems Inc (DCTH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus DCTH at N/M Forward P/E and 5.2% operating margin (+70.7% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against DCTH sits in BREAKOUT (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
CVM 23.0x vs DCTH N/M Fwd P/E
Growth & Margin Winner DCTH
Op Margin 0.0% vs 5.2% ยท YoY -62.7% vs +70.7%
Momentum & Technical Winner DCTH
1Y -77.5% vs +128.6% ยท 52W Pos 10% vs 80%
Options & Structure Winner DCTH
BREAKDOWN (N/A IV) vs BREAKOUT (43rd %ile IV)
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0
DCTH NASDAQ
Delcath Systems Inc
Surgical & Medical Instruments & Apparatus
$19.68
-4.23% 1D
Market Cap $743.8M
1M Return +39.77%
1Y Return +128.57%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 50.0 Fund 38.0 Flow 60.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVM -77.48% DCTH +128.57% Spread: +196.36 pp (DCTH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CVM Revenue DCTH Revenue CVM Op. Margin DCTH Op. Margin Margin Edge
FY2013 $0M $0M -12450.1% -4179.6% DCTH
FY2014 $0M $0M -9721.4% -1805.8% DCTH
FY2015 N/A $0M N/A -870.6% DCTH
FY2021 N/A $0M N/A -690.0% DCTH
FY2022 N/A $0M N/A -1245.1% DCTH
FY2023 N/A $0M N/A -1849.0% DCTH
FY2024 N/A $40M N/A -33.4% DCTH
FY2025 N/A $90M N/A 0.8% DCTH

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVM (4) vs DCTH (6)
Institutional Metric CVM DCTH Criterion Row Winner
Market Capitalization Scale $20.9M $743.8M Larger Scale DCTH
Trailing P/E Ratio Valuation 23.0x 133.6x Lower Multiple CVM
Forward P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Revenue Growth (YoY) Growth -62.7% +70.7% Higher Growth DCTH
Operating Margin (TTM) Profitability 0.0% 5.2% Higher Margin DCTH
Net Profit Margin Profitability 0.0% 6.0% Higher Margin DCTH
Return on Equity (ROE) Capital Efficiency -252.5% 5.4% Higher ROE DCTH
52-Week Range Position Momentum 10% ($1โ€“$8) 80% ($8โ€“$23) Stronger Trend DCTH
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 120% Vol 1.63ฮฒ ยท 131% Vol Lower Realized Risk CVM
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 35.9 / 100 (SELL) Higher Composite CVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVM vs DCTH Buy Guide
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DCTH BREAKOUT
66d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live DCTH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVM nor DCTH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.